Objective: The objective of this study is to formulate a tablet that fits in the size range of mini-tablets using wax matrix forming substances, allows variation of drug dose and study of drug release kinetics of the dosage form.
INTRODUCTION
The lipids we use in preparation of pharmaceutical formulations have their origin in the food stuff used. The lipids attract attention as they can help improve pharmaceutical product cycle and are cost-effective. They are used in various drug delivery systems intended to improve oral bioavailability and esthetics of the drug [1] .
Mini-tablets are multiple unit dosage forms developed to retain advantages of formulations like pellets that include uniformity of drug release, less tendency of dose dumping, and greater patience compliance. However, mini-tablets score more advantages such as improved mechanical strength, more dose loading capacity, and uniformity of size and shape. Mini-tablets have a diameter in the range of 2 mm and can be presented filled in capsules like pellets or separately which serves an advantage of dose variation with the age and clinical condition of the patient [2] .
Montelukast sodium, a leukotriene receptor antagonist, blocks the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1 in lungs and bronchial tubes to decrease bronchoconstriction and inflammation. It is used in treatment of asthma and for symptomatic relief from seasonal allergies. Montelukast sodium is hygroscopic, optically active, white to off-white powder, freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile with a melting point 135.5°C and half-life 2.2-5.5 hrs [3] .
The drug dispersed evenly in the lipid matrix diffuses when exposed to the dissolution medium. The drug on the surface dissolves forming pores for the dissolution medium to penetrate. Then the drug dissolves. Release follows square of time release kinetics. In case of a highly soluble drug such as Montelukast sodium, or large amount of soluble product in the matrix, the porosity of the matrix increases with dissolution time [4] .
Erosion and/or partial solubilization may occur during the dissolution depending on the composition of the fatty compounds. In general, the erosion or solubilization of triglycerides is achieved in vivo by enzymes which hydrolyze the ester bonds of triglycerides. There are many enzymes called esterases, lipases which hydrolyze the ester bonds of triglycerides. These compounds can then be easily absorbed through the intestinal wall. However, the very long chains, C16-C22 (in case of glyceryl behenate, cetyl alcohol, and glyceryl monostearate) are hardly hydrolyzed, and hence, poor absorption through the intestinal wall [5] .
The objective, therefore, is to formulate a tablet that fits in the size range of mini-tablets, allows variation of drug dose and study of drug release kinetics of the dosage form.
METHODS
Montelukast sodium was obtained as a gift sample from Zim Laboratories, Nagpur, pharmaceutical grade microcrystalline cellulose, glyceryl monostearate, magnesium stearate, Talc were obtained from HiMedia, Mumbai, polyethylene glycol (PEG) 4000, PEG 6000, carnauba wax and PEG 500 were obtained from Research Laboratories, Mumbai. Rice bran wax was procured from Maheshwari rice mills, Gondia. Solvents were obtained from SD Fine Chemicals and were distilled before use.
Deshpande and Wasule n-hexane followed by isopropanol. The defatted wax is then bleached with sodium borohydride to yield a white compound which can be used further. About 100 g of crude rice bran wax was refluxed with about 1 L of n-hexane at about 50°C for 3 hrs. The mixture was cooled to about 20°C and was filtered and dried. This dried wax, about 50 g was then refluxed with about 500 ml of isopropyl alcohol at about 80°C for 3 hrs and was then cooled to about 20°C and the residue was filtered. Most of the oil content is removed by n-hexane washing and remaining polar oils and lipids are washed in the isopropyl alcohol washing to yield a brownish wax which is harder to feel.
Bleaching of the defatted wax
The color is due to the presence of resinous matter which can be removed by bleaching. The defatted wax, about 50 g is refluxed with isopropyl alcohol at about 80°C in a two neck round bottomed flask fitted with a rubber cork. When the desired temperature is reached, the wax is bleached by drop wise addition of 10% solution of sodium borohydride. The process yields a separate layer of resinous matter, being more polar in nature, separates and the wax remains in the molten state. The mixture is filtered when hot to separate resinous matter and the white wax separates as solid crystals from the filtrate on cooling.
The rice bran wax was evaluated for its content and quality. By same procedure, carnauba wax was also purified and bleached.
Preparation of blends
Four different wax matrix formers were used namely PEG 4000, GMS, carnauba wax (purified and bleached), and rice bran wax (purified and bleached) in different batches and their influence on the tablet properties was compared. The wax matrix former was passed through a sieve no. 30 (ASTM). The drug and the other excipients were added after being passed through sieve no. 80 (ASTM) to the wax matrix former.
Evaluation of blends for compressed mini-tablets [7-12]
The blends were evaluated for their compressibility by measuring the angle of repose, Carr's index and Hauser's ratio.
Angle of repose
It is determined by allowing a powder to flow through a funnel and fall freely onto a surface. Further addition of powder is stopped as soon as the pile touches the tip of the funnel. A circle is drawn around the pile without disturbing it. The height and diameter of the resulting cone are measured. The same procedure is repeated three times and the average value is taken. Angle of repose is calculated using the following equation:
Tan θ=h/r
Where h = Height of the powder cone; r = Radius of the powder.
Bulk density
Unless otherwise specified, pass a quantity of material sufficient to complete the test through a 1.00 mm (no. 18 ASTM) screen to break up agglomerates that may have formed during storage. Into a dry 250 ml cylinder introduce, without compacting, approximately 100 g of the test sample (M) weighed with 0.1% accuracy. If it is not possible to use 100 g, the amount of the test sample and the volume of the cylinder may be modified. Select a sample mass having an untapped apparent volume of 150-250 ml. A 100 ml cylinder is used for apparent volumes between 50 and 100 ml. Fill the cylinder carefully. Carefully level the powder without compacting, if necessary, and read the unsettled apparent volume (V o ). Calculate the bulk density, in g/ml, using the formula:
Tapped density [11] Accurately weighed quantity of powder is introduced into a measuring cylinder. Mechanically tap the cylinder containing the sample by raising the cylinder and allowing it to drop under its own weight using a suitable mechanical tapped density tester at a nominal rate of 300 drops/minutes. Tap the cylinder 500 times and measure the tapped volume (V a ). Repeat the operation for an additional 750 tapings and again measure the tapped volume as (V b ).
If the difference between V a and V b is <2%, V b is the final tapped volume (Vf) If the difference is higher, repeat the tapings for an additional 1250 times, and then, the tapped density can be calculated using the following formula (United States pharmacopoeia, 2004).
Where M = Weight of the sample taken; V f = Final tapped volume.
Carr's index and Hausner's ratio [11]
The compressibility index of granules can be determined using Carr's compressibility index, and can be determined by the following formula: The compressibility index of granules can be determined using Carr's compressibility index, and can be determined by the following formula:
The compressibility index is calculated by the formula:
Hausner's ratio is calculated as:
The compressibility index is evaluated for the interpretation of the flow of the granules. The relationship is presented in Table 1 .
Size distribution of mixture was checked and the blends were compressed in Cemach make R&D press at 5 tons pressure.
Evaluation of mini-tablets [12]
The mini-tablets were evaluated for parameters such as weight variation, thickness, hardness, friability, disintegration time, dissolution time, taste and mouth feel. a. Tablet thickness: Thickness was measured using vernier caliper. b. Weight variation: Randomly selected 20 tablets from the lot were weighted individually to check for weight variation. Weight variation specification as per IP is shown in Table 2 . c. Friability: Preweighed tablets were placed in the Roche Friabilator for 100 revolutions. At the end of test tablets were dusted and 2 303 C r = % remaining, C 0 = Initial concentration of drug, K 1 = First-order constant, t = Time. iii. T. Higuchi model [14] If the drug is dispersed in homogenous matrix instead of being complexed or dissolved, the release kinetics are altered. Higuchi developed a mathematical model for analysis of such system: The release of dispersed drugs by diffusion from a stationary matrix such as ointment. The expression of drug released per unit area from slab takes form:
Where M t is the amount of drug released per unit area at time t, D and C s are the diffusion coefficient and solubility of the drug in the polymer, respectively, and A is the concentration of the drug initially present in the matrix. When A>>C s , the equation reduces to:
This is known as Higuchi's square root of t equation, which describes linear relationship between the amount of drug released and t 1/2 provided D, A and C s are constant. It was indicated that the model would only be suitable for systems where A exceeds C s by a factor of three or more and it has been reported for polymer dispersions containing as less as 1% of drug. In this model, it is assumed that the solid rug dissolves from the surface layer and this layer becomes exhausted of drug particles. iv. Korsmeyer and Peppas model [15] [16] [17] Korsmeyer et al. derived a simple relationship, which described drug release from a polymeric system:
Where M t /M a is the fraction of drug released, t is the release time, k is a kinetic constant (with units of t n ) incorporating structural and geometric characteristics of the release device and n is the release exponent indicative of the mechanism of release. This equation can be used to analyze the first 60% of a release curve where the release is linearly related to t n , regardless of geometric shape. Peppas (1985) , Sahlin and Peppas (1989) , have shown also that two competing release mechanisms, a Fickian diffusional release and a Case II relaxational release, are the limits of this phenomenon.
Fickian diffusional release occurs by the usual molecular diffusion of the drug due to a chemical potential gradient. Case II relaxational release is the drug transport mechanism associated with stresses and state-transition in hydrophilic glassy polymers, which swell in water or biological fluids. This term also includes polymer disentanglement and erosion. The value of the exponent for Case II transport mechanism is twice that of pure Fickian diffusional mechanism.
RESULTS
Rice bran wax and carnauba wax were evaluated for their physicochemical properties as per the methods specified in literature and the results are recorded as follows in Table 3 .
Evaluation of granules
The formulation blends were considerably different in their physical and flow properties. The flow properties and packing properties of the blends show desirable characteristics for compression ( Table 4) .
Evaluation of mini-tablets
The mini-tablets were prepared by direct compression of blends using Cemach make R&D press. The thickness and hardness of the tablets was measured during compression regularly. The tablets were subjected to weight variation, friability, and assayed for drug content and the results are reported in Table 5 .
Dissolution profile
The dissolution profile of mini-tablets is recorded in the following Table 6 . Table 7 shows drug release kinetic studies.
Drug release kinetic studies

DISCUSSION
According to the physicochemical properties of the waxes recorded in Table 3 , it can be concluded that the purification process rendered the waxes food-grade [6] . The different blends were prepared as per amounts specified in Table 8 . The blends were evaluated for compressibility and other properties as per the values and methods given in Tables 1, 2 , 9 and 10. From the precompression parameters given in Tables 4 and 11 , it is clear that the granules were suitable for compression. They possessed acceptable flow properties and hence were considered for compression. Carnauba wax and rice bran wax are The dissolution profile of the formulations as shown in Table 6 endorsed the influence of nature of ingredients used as matrix formers. It can be easily inferred from Fig. 1 that the rate of drug dissolution is slower where carnauba wax and rice bran wax but the rate retardation is less may be due to small size of the tablets.
The release kinetics data when fitted as shown in Table 7 , to different kinetic models, zero-order drug release was predominant as reflected form the regression values given for each equation.
Mechanism of drug release obtained by Korsmeyer-Peppas model was super Case II transport type. This is due to Fickian diffusion taking 
